GlobalData PLC Acquisition of Life Sciences business (1926L)

TIDMDATA

RNS Number : 1926L

GlobalData PLC

09 September 2021

9 September 2021

GlobalData Plc

("GlobalData" or the "Company")

Acquisition of Life Sciences business

GlobalData Plc, the leading provider of industry intelligence, today announces its agreement to acquire the Life Sciences business of IHS Markit Ltd. ("LS").

LS offers comprehensive and independent coverage of drug pricing, reimbursement and market access trends, as well as healthcare forecasts and healthcare economic data microsimulation modelling. These capabilities represent a strategic addition to our existing pharmaceuticals vertical and will result in a true end-to-end offering with industry leading breadth and depth for our clients.

Completion, which is subject to certain closing conditions, is expected to occur during Q4 of 2021 and will be funded from the Group's existing cash resources and banking facilities.

Commenting on the acquisition Mike Danson, Chief Executive Officer, said:

"The Life Sciences acquisition represents a strategic bolt-on to our already strong pharmaceuticals data, insights and analytics services. The addition of drug pricing data, as well as other critical Life Sciences data and analysis, further confirms our industry leading breadth and depth in the pharmaceuticals space.

I would like to take this opportunity to welcome our new group of highly talented colleagues to the Group and wish them every success for the future within GlobalData"

Gustav Ando, Vice President and Head of Life Sciences at IHS Markit, added:

"We are looking forward to becoming an integral part of the GlobalData Pharma and Life Sciences Team. This unique combination will enable us to provide our current and expanded client base with a much broader service offering, through synergy with existing GlobalData services, and on a single fully integrated platform."

ENQUIRIES:

GlobalData Plc

Mike Danson, Chief Executive Officer 0207 936 6400

Graham Lilley, Chief Financial Officer

Brokers

Bill Hutchings/ Mose Adigun - J.P. Morgan Cazenove (Nomad and joint broker) 0207 742 4000

Adam Miller - HSBC (Joint broker) 0207 991 8888

Erik Anderson/ Alina Vaskina - Panmure Gordon (Joint Broker) 020 7886 2500

Hudson Sandler

Nick Lyon 0207 796 4133

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQDKFBDDBKBQCK

(END) Dow Jones Newswires

September 09, 2021 02:00 ET (06:00 GMT)